治疗后的胶质母细胞瘤中68Ga-前列腺特异性膜抗原-11 PET/CT显示的假性进展
本文报告一例40岁男性右侧额颞叶胶质母细胞瘤患者,术后放疗后1个月,对比增强MRI显示右侧海马区新发强化病灶,68Ga-PSMA-11 PET/CT亦为阳性;保守随访中两种影像均显示新发病灶消退,提示假性进展。
要点
- 胶质母细胞瘤标准治疗后,假性进展与真性进展的鉴别在对比增强MRI上存在困难。
- 近年来68Ga-PSMA PET/CT被提出在胶质母细胞瘤复发诊断中具有较高准确性。
- 本例治疗后新发强化病灶在68Ga-PSMA-11 PET/CT上阳性,保守随访后病灶消退,提示假性进展。
核心结论
- 保守随访中对比增强MRI与68Ga-PSMA-11 PET/CT均显示新发病灶消退,提示为假性进展。
研究设计与样本
- 本文为病例报告,报告一例40岁男性右侧额颞叶胶质母细胞瘤患者,接受手术和放疗。
主要发现
- 治疗后1个月对比增强MRI显示右侧海马区新发强化病灶,68Ga-PSMA-11 PET/CT亦为阳性。
- 保守管理随访中,对比增强MRI和68Ga-PSMA-11 PET/CT均显示新发病灶消退。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
After standard treatment of glioblastoma, pseudoprogression versus true progression is a clinical challenge. Indeed, to differentiate these 2 on contrast MRI (cMRI) is problematic. In recent time, Ga-prostate-specific membrane antigen-11 (Ga-PSMA) PET/CT has been suggested to have high accuracy in glioblastoma recurrence. We present a case of a 40-year-old man with right frontotemporal glioblastoma underwent surgery and radiotherapy. One month posttreatment cMRI showed a new enhancing lesion in the right hippocampal region, which was also positive on Ga-PSMA-11 PET/CT. On follow-up with conservative management, both cMRI and Ga-PSMA-11 PET/CT showed regression in new lesion, hence suggest pseudoprogression.
引用
- Gupta M, Choudhury PS, Gairola M, et al. Pseudoprogression on 68Ga-Prostate-Specific Membrane Antigen-11 PET/CT in a Treated Glioblastoma. Clin Nucl Med. 2020. PMID: 32520501. doi:10.1097/RLU.0000000000003121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。